Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Laryngol Otol ; 134(1): 68-73, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31918788

ABSTRACT

OBJECTIVE: To determine whether patients would have equivalent or improved outcomes when receiving non-surgical management versus surgical removal for vocal process granulomas. METHODS: A chart review was performed for 53 adults with vocal process granulomas. All patients received baseline anti-reflux treatment consisting of twice-daily proton pump inhibitors and vocal hygiene education. Further treatment approaches were divided into non-surgical (i.e. inhaled corticosteroids, voice therapy, botulinum toxin injections) and surgical groups. Subjective parameters (Voice Handicap Index 10 and Reflux Symptom Index) and outcomes were tabulated and statistically compared. Cause of granuloma was also analysed to determine if this influenced outcomes. RESULTS: Of 53 patients, 47 (89 per cent) experienced reduction in granuloma size, while 37 (70 per cent) experienced complete resolution. The rate of complete granuloma resolution after initial treatment strategy alone was significantly higher in non-surgical compared to surgical patients (67 and 30 per cent, respectively; p = 0.039). No difference in outcome was seen between iatrogenic and idiopathic granulomas. CONCLUSION: Non-surgical patients were more likely to experience initial treatment success than those who underwent surgical removal. Continued emphasis should be placed on conservative treatment options prior to surgery for patients with this condition.


Subject(s)
Granuloma/therapy , Laryngitis/therapy , Proton Pump Inhibitors/therapeutic use , Vocal Cords/physiopathology , Adult , Aged , Combined Modality Therapy , Disease Management , Female , Humans , Male , Middle Aged , Otorhinolaryngologic Surgical Procedures , Proton Pump Inhibitors/pharmacology , Treatment Outcome , Vocal Cords/drug effects , Voice Quality/drug effects , Voice Training
2.
J Laryngol Otol ; 132(9): 822-826, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30208975

ABSTRACT

OBJECTIVE: To quantitatively test the hypothesis that older patients have increased thyroarytenoid muscle atrophy by comparing thyroarytenoid muscle volumes across different age groups. METHODS: A retrospective chart review was conducted. The study included 111 patients with no history of laryngeal pathology. Two investigators reviewed magnetic resonance imaging studies of these patients and manually traced the thyroarytenoid muscles on multiple slices bilaterally. Thyroarytenoid muscle volumes were then computed using imaging analysis software. Patients were stratified into three age groups (18-50 years, 51-64 years, and 65 years or older) for comparison. RESULTS: Intra- and inter-rater reliabilities were excellent for all measurements (intraclass correlation co-efficient > 0.90). There was no statistically significant difference in the mean volumes of left and right thyroarytenoid muscles in all age and gender groups. CONCLUSION: Given the lack of statistically significant difference in thyroarytenoid muscle volume between age groups on magnetic resonance imaging, the prevailing assumption that age-related thyroarytenoid muscle atrophy contributes to presbyphonia should be re-examined.


Subject(s)
Laryngeal Muscles/diagnostic imaging , Magnetic Resonance Imaging/methods , Muscular Atrophy/diagnostic imaging , Vocal Cords/diagnostic imaging , Adolescent , Adult , Aged , Aging/physiology , Female , Humans , Laryngeal Diseases/diagnostic imaging , Laryngeal Diseases/pathology , Laryngeal Muscles/anatomy & histology , Laryngeal Muscles/pathology , Male , Middle Aged , Muscular Atrophy/pathology , Retrospective Studies , Vocal Cords/pathology , Voice Quality/physiology , Young Adult
3.
Anesth Analg ; 90(4): 872-7, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10735791

ABSTRACT

UNLABELLED: The bispectral index (BIS) has been developed in adults and correlates well with clinical hypnotic effects of anesthetics. We investigated whether BIS reflects clinical markers of hypnosis and demonstrates agent dose-responsiveness in infants and children. In an observational arm of this study, BIS values in children undergoing general anesthesia were observed and compared with similar data collected previously in a study of adults. In a second arm of the study, a range of steady-state end-tidal concentrations of sevoflurane was administered and corresponding BIS documented. Data were examined for differences between infants (0-2 yr) and children (2-12 yr). No difference was seen in BIS values in children before induction, during maintenance, and on emergence compared with adult values. There was no difference in BIS between infants and children at similar clinical levels of anesthesia. In children and infants, BIS was inversely proportional to the end-tidal concentration of sevoflurane. The sevoflurane concentration for a BIS = 50 (95% confidence interval) was significantly different: 1. 55% (1.40-1.70) for infants versus 1.25% (1.12-1.37) for children. Although validation with specific behavioral end points was not possible, BIS correlated with clinical indicators of anesthesia in children as it did in adults: as depth of anesthesia increased, BIS diminished. BIS correlated with sevoflurane concentration in infants and children. The concentration-response difference between infants and children was consistent with data showing that minimum alveolar concentration is higher in children less than 1 yr of age. IMPLICATIONS: The use of bispectral index (BIS) during general anesthesia improves the titration of anesthetics in adults. The data from this study suggest that the same equipment and method of electroencephalogram analysis may be applied to infants and children.


Subject(s)
Anesthetics, Inhalation/pharmacology , Electroencephalography , Methyl Ethers/pharmacology , Monitoring, Physiologic/instrumentation , Child , Child, Preschool , Dose-Response Relationship, Drug , Female , Humans , Infant , Male , Methyl Ethers/pharmacokinetics , Sevoflurane
SELECTION OF CITATIONS
SEARCH DETAIL
...